National Healthcare Properties, Inc. filed 4 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-14. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
On September 11, 2026, Edward M. Weil, Jr. notified National Healthcare Properties, Inc. (the "Company") of his decision to resign from the board of directors of the Company, effective as of September 11, 2026.
Appointed: Albert M. Campbell, Director, effective 2026-08-10
On August 4, 2026, upon the recommendation of the Compensation and Corporate Governance Committee (the "CCG Committee") of the Board of the Directors (the "Board") of the Company, the Board increased the size of the Board from six to seven directors and, effective August 10, 2026, elected Albert M. Campbell to serve as a member of the Board.
Reported
Departure of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Reported
As disclosed in the Registration Statement filed in connection with the Offering, the Company's board of directors (the "Board") granted listing equity awards to certain of its directors, named executive officers and employees, subject to and effective upon the completion of the Offering.
Find people with the same kind of experience as the Director at National Healthcare Properties, Inc., with the record behind each one.
Find candidates like Director at National Healthcare Properties, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time National Healthcare Properties, Inc. is in the news or changes leadership.
Get an alert when National Healthcare Properties, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for National Healthcare Properties, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.